Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets
Modified release of furosemide from tablet formulations is preferred by patients, because of physiological problems, acute diuresis being the most serious, compared to the forms designed for immediate release. With this in view, we aimed at achieving furosemide’s longer gastric retention and waste m...
Saved in:
Main Authors: | Vlachou Marilena, Geraniou Efthymia, Siamidi Angeliki |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2020-03-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2020-0010 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quality assessment of furosemide tablet generics used in a teaching hospital in Nigeria
by: Abdurrahman Umar, et al.
Published: (2025-02-01) -
Some variables affecting the characteristics of Eudragit E-sodium alginate polyelectrolyte complex as a tablet matrix for diltiazem hydrochloride
by: Yusif Rehab Mohammad, et al.
Published: (2014-03-01) -
Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods
by: Kashiwagura Yasuharu, et al.
Published: (2023-03-01) -
Core-in-cup/liquisol dual tackling effect on azelnidipine buccoadhesive tablet micromeritics, in vitro release, and mucoadhesive strength
by: Rashad Amira A., et al.
Published: (2019-09-01) -
Compressibility of tableting materials and properties of tablets with glyceryl behenate
by: Mužíková Jitka, et al.
Published: (2015-03-01)